Melbourne, Australia; 15 November 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) refers to its Notice of Annual General Meeting dated 27 October 2023 (Notice).

Starpharma wishes to clarify an item in the Explanatory Memorandum to Resolution 5 Approval of Starpharma Holdings Limited Employee Performance Rights Plan.

The Explanatory Memorandum stated that persons who are eligible to participate in the Employee Performance Rights Plan (defined in the Notice as “Eligible Persons”) included Directors. The Explanatory Memorandum should state that Executive Directors are Eligible Persons and may participate in the Employee Performance Rights Plan, and that Non-Executive Directors may not participate in the Plan.

As such, the definition of Eligible Persons is updated to: Eligible Persons means any employee (or prospective employee) of one or more Group Companies or any other person, including an Executive Director of the Company, excluding Non-Executive Directors, as selected by the Board to participate in the Employee Performance Rights Plan.

View/download the ASX Announcement, here.